U.S. flag

An official website of the United States government

NM_001099274.3(TINF2):c.802G>C (p.Val268Leu) AND multiple conditions

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Aug 3, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002482667.1

Allele description [Variation Report for NM_001099274.3(TINF2):c.802G>C (p.Val268Leu)]

NM_001099274.3(TINF2):c.802G>C (p.Val268Leu)

Gene:
TINF2:TERF1 interacting nuclear factor 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q12
Genomic location:
Preferred name:
NM_001099274.3(TINF2):c.802G>C (p.Val268Leu)
HGVS:
  • NC_000014.9:g.24240678C>G
  • NG_016650.1:g.6997G>C
  • NG_054634.1:g.13262C>G
  • NM_001099274.3:c.802G>CMANE SELECT
  • NM_001363668.2:c.697G>C
  • NM_012461.3:c.802G>C
  • NP_001092744.1:p.Val268Leu
  • NP_001350597.1:p.Val233Leu
  • NP_036593.2:p.Val268Leu
  • LRG_342t1:c.802G>C
  • LRG_342t2:c.802G>C
  • LRG_342:g.6997G>C
  • LRG_342p1:p.Val268Leu
  • LRG_342p2:p.Val268Leu
  • NC_000014.8:g.24709884C>G
  • NM_001099274.1:c.802G>C
Protein change:
V233L
Links:
dbSNP: rs369926102
NCBI 1000 Genomes Browser:
rs369926102
Molecular consequence:
  • NM_001099274.3:c.802G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001363668.2:c.697G>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_012461.3:c.802G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Revesz syndrome
Synonyms:
Exudative retinopathy with bone marrow failure; DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 5
Identifiers:
MONDO: MONDO:0009990; MedGen: C1327916; Orphanet: 3088; OMIM: 268130
Name:
Dyskeratosis congenita, autosomal dominant 1 (DKCA1)
Synonyms:
Dyskeratosis congenita autosomal dominant; Dyskeratosis congenita Scoggins type
Identifiers:
MONDO: MONDO:0007485; MedGen: C4551974; Orphanet: 1775; OMIM: 127550
Name:
Dyskeratosis congenita, autosomal dominant 3
Identifiers:
MONDO: MONDO:0013522; MedGen: C3151445; OMIM: 613990

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Help
Submission AccessionSubmitterReview Status
(Assertion method)		Clinical Significance
(Last evaluated)		OriginMethodCitations
SCV002782426Fulgent Genetics, Fulgent Genetics
criteria provided, single submitter

(ACMG Guidelines, 2015)		Uncertain significance
(Aug 3, 2021) 		unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Fulgent Genetics, Fulgent Genetics, SCV002782426.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024